In 1951, scientists took cancer cells from a patient named Henrietta Lacks without her knowledge. Unlike other human cells, which die after a few divisions, these cells divided indefinitely. Known as HeLa cells, they became the first immortal human cell line. Today, they are used worldwide for polio vaccines, gene mapping, and cancer research. Their total mass now vastly exceeds Henrietta's original body weight.
The Biopsy That Changed Modern Biology
In early 1951, a thirty-one-year-old African American mother of five named Henrietta Lacks visited The Johns Hopkins Hospital in Baltimore to treat severe vaginal bleeding. Doctors diagnosed her with an aggressive, malignant epidermoid carcinoma of the cervix. During her radium treatments, a sample of her tumor tissue was excised without her knowledge or permission, which was common clinical practice at the time. The tissue sample was delivered to Dr. George Otto Gey, head of the tissue culture research laboratory at Johns Hopkins, who had spent decades attempting to grow human cells outside the body.
Until that point, human cells cultivated in laboratory glassware invariably died after a few rounds of division. Cells had a fixed lifespan, entering a state of senescence and degrading before scientists could perform long-term experiments. Lacks's tumor cells, however, behaved in a way Gey had never witnessed. Instead of perishing, they divided at an astonishing rate, doubling their population roughly every twenty-four hours. Gey designated the new culture HeLa, using the first two letters of the patient's first and last names. Henrietta Lacks died of metastatic cancer in October 1951, but the cells taken from her cervix continued to live, multiply, and thrive.
The Machinery of Cellular Immortality
Normal human somatic cells are subject to the Hayflick limit, a natural ceiling on the number of times a cell population can divide before reaching cellular senescence. Each time a healthy cell replicates, the protective caps at the ends of its chromosomes, called telomeres, lose a small amount of DNA. Eventually, the telomeres become critically short, triggering a permanent halt to replication or cell death. In HeLa cells, this protective countdown is entirely disabled by an overactive version of the enzyme telomerase, which continuously rebuilds telomeric DNA and allows the cells to divide without end.
This immortality was catalyzed by a high-risk strain of the human papillomavirus, HPV-18, which had integrated its own genetic material into the genome of Lacks's cervical cells. The viral insertion disrupted key tumor-suppressor pathways, particularly inactivating the p53 gene, which normally regulates DNA repair and triggers programmed cell death in damaged cells. In addition to viral integration, HeLa cells possess an extremely abnormal genome known as an aneuploid karyotype. Instead of the standard 46 human chromosomes, HeLa cells typically contain between 70 and 80 heavily mutated, rearranged, and duplicated chromosomes, giving them an exceptional biological resilience that allows them to thrive in varied culture conditions.
Fueling the Breakthroughs of 20th-Century Science
The ability to culture human cells continuously and cheaply revolutionized medical research across the globe. One of the earliest major applications of HeLa cells occurred during the development of the polio vaccine by Jonas Salk in the early 1950s. To test the vaccine at a national scale, researchers needed vast numbers of susceptible human cells to culture the poliovirus safely and efficiently. A mass-production facility was established at the Tuskegee Institute, producing trillions of HeLa cells each week and shipping them to laboratories nationwide, which directly accelerated the testing and rollout of the polio immunization campaign.
In the decades that followed, HeLa cells became standard biological tools across numerous scientific fields. They were used to study the cellular mechanics of cancer, analyze the effects of radiation and atomic testing on human tissue, and assess the toxicity of pharmaceutical drugs and household chemicals. HeLa cells played a key role in early gene mapping, helped researchers understand how viruses such as HIV infect host cells, and were even sent on early space flights to evaluate the impact of zero gravity and cosmic radiation on human cellular division.
The Invisible Crisis of Lab Contamination
Because HeLa cells divide so rapidly and survive in harsh environments, they also introduced an unexpected hazard to laboratory research: cross-contamination. HeLa cells can travel through the air on microscopic dust particles, transfer via unwashed pipettes or gloved hands, and easily outcompete other cell cultures sharing the same workspace. If even a single HeLa cell entered a petri dish containing a different human cell line, it would quickly overgrow and replace the original culture entirely within a few weeks.
The extent of this problem became apparent in 1966, when geneticist Stanley Gartler revealed that dozens of widely used, supposedly distinct cell lines—including lines thought to represent liver, heart, and kidney tissues—shared rare genetic markers unique to HeLa. Many researchers had spent decades unknowingly conducting experiments on cervical cancer cells rather than the specific organs they intended to study. This realization forced laboratories worldwide to overhaul sterile techniques, establish stricter quality-control protocols, and develop genetic fingerprinting methods to verify cell identities.
Consent, Bioethics, and the Lacks Legacy
While HeLa cells generated billions of dollars in commercial products, patents, and scientific prestige, Henrietta Lacks's family remained completely unaware of the cell line's existence for more than two decades. It was not until the 1970s, when scientists contacted her children to request blood samples for genetic research, that the family learned her cells were still alive and being bought and sold across the world. The family received no financial compensation, and their medical records and personal genetic details were published in scientific journals without their informed consent.
The revelation of how HeLa cells were obtained and commercialized became a central case study in modern bioethics, sparking debates over patient rights, informed consent, and the ownership of biological materials. In 2013, after researchers sequenced and publicly released the full HeLa genome, the National Institutes of Health established an agreement with the Lacks family that granted them representation on a review panel governing access to HeLa genetic data. Henrietta Lacks's story continues to shape modern regulatory standards, ensuring that human tissue donors are treated with transparency, autonomy, and respect.
Key takeaways
•HeLa cells were taken from Henrietta Lacks in 1951 without her knowledge, becoming the first immortal human cell line ever successfully cultured in a laboratory.
•Their biological immortality stems from HPV-18 viral integration and overactive telomerase enzymes, which prevent the normal chromosome shortening that limits cellular lifespan.
•HeLa cells enabled critical medical milestones, including the mass testing of the polio vaccine, cancer research, gene mapping, and antiviral treatments.
•The unconsented use and commercialization of the cells led to major reforms in biomedical ethics, patient autonomy, and the governance of human tissue research.